Special items: Ovarian Cancer and Us blog best viewed in Firefox
▼
Monday, January 02, 2012
Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations : Modern Pathology
ARID1A is a recently identified tumor suppressor gene that is mutated in ~50%
of ovarian clear-cell carcinomas. This mutation is associated with loss
of ARID1A protein expression as assessed by immunohistochemistry. The
present study aimed at determining the timing of the loss of ARID1A
protein expression during the development of ovarian clear-cell
carcinoma and assessing its relevance in correlation to PIK3CA gene
mutations......
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.